相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MK212, a 5-hydroxytryptamine 2C receptor agonist, reverses prepulse inhibition deficits in the medial prefrontal cortex and ventral hippocampus
Guanlong Guo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
Amberlyst-15 catalysed synthesis of novel indole derivatives under ultrasound irradiation: Their evaluation as serotonin 5-HT2C receptor agonists
Gangireddy Sujeevan Reddy et al.
BIOORGANIC CHEMISTRY (2021)
5-HT2C agonists and antagonists block different components of behavioral responses to potential, distal, and proximal threat in zebrafish
Rhayra Xavier do Carmo Silva et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)
Identification of Novel 1-O-Substituted Aporphine Analogues as Potent 5-HT2C Receptor Agonists
Qi Mao et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
John L. Waddington
ACTA PHARMACOLOGICA SINICA (2020)
Recent advances in dopaminergic strategies for the treatment of Parkinson's disease
Qi Mao et al.
ACTA PHARMACOLOGICA SINICA (2020)
A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts
Bingjie Zhang et al.
ACS CENTRAL SCIENCE (2020)
Adjunctive effect of the serotonin 5-HT2C receptor agonist lorcaserin on opioid-induced antinociception in mice
Salvador Sierra et al.
NEUROPHARMACOLOGY (2020)
Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties
Eric A. Wold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial
John Sharretts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting
Philippe De Deurwaerdere et al.
FRONTIERS IN PHARMACOLOGY (2020)
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Terakado Kimura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway
Chao-jun Han et al.
ACTA PHARMACOLOGICA SINICA (2019)
Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development
Eric A. Wold et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Effect of the 5-HT2C Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study
Sara Whitestone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor
Yulong Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology
Yao Peng et al.
CELL (2018)
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
ProTox-II: a webserver for the prediction of toxicity of chemicals
Priyanka Banerjee et al.
NUCLEIC ACIDS RESEARCH (2018)
Structural determinants of 5-HT2B receptor activation and biased agonism
John D. McCorvy et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications
Guiping Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation
Terry Kenakin
MOLECULAR PHARMACOLOGY (2017)
5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice
Vladimir M. Pogorelov et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker et al.
CELL (2017)
Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model
Jo Sourbron et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models
Jianjun Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders
Giuseppe Di Giovanni et al.
PHARMACOLOGY & THERAPEUTICS (2016)
5-HT2C receptors in psychiatric disorders: A review
A. Chagraoui et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
A Computational Perspective on Drug Discovery and Signal Transduction Mechanism of Dopamine and Serotonin Receptors in the Treatment of Schizophrenia
Peng Lian et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
Assessing an Ensemble Docking-Based Virtual Screening Strategy for Kinase Targets by Considering Protein Flexibility
Sheng Tian et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Biased Ligand Modulation of Seven Transmembrane Receptors (7TMRs): Functional Implications for Drug Discovery
Craig C. Correll et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective
Jeremy Shonberg et al.
MEDICINAL RESEARCH REVIEWS (2014)
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
A Novel Aminotetralin-Type Serotonin (5-HT)2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses
Clinton E. Canal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders
Na Ye et al.
CHEMICAL REVIEWS (2013)
The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: A model for schizophrenia
Eiichi Jodo
JOURNAL OF PHYSIOLOGY-PARIS (2013)
Structural Features for Functional Selectivity at Serotonin Receptors
Daniel Wacker et al.
SCIENCE (2013)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Computational Modeling of Structure-Function of G Protein-Coupled Receptors with Applications for Drug Design
Y. Y. Li et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo
J. Shawn Goodwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Serotonin receptors
David E. Nichols et al.
CHEMICAL REVIEWS (2008)
Physical Interaction of Calmodulin with the 5-Hydroxytryptamine2C Receptor C-Terminus Is Essential for G Protein-independent, Arrestin-dependent Receptor Signaling
Marilyne Labasque et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity
Judith A. Siuciak et al.
NEUROPHARMACOLOGY (2007)
Advances in development of dopaminergic aporphinoids
Ao Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity
Karen L. Marquis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Different effects of phencyclidine and methamphetamine on firing activity of medial prefrontal cortex neurons in freely moving rats
E Jodo et al.
BRAIN RESEARCH (2003)
分享论文
